骨诱导因子(OGN)重组蛋白

Recombinant Osteoglycin (OGN)

OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor

  • 骨诱导因子(OGN)重组蛋白 产品包装(模拟)
  • 骨诱导因子(OGN)重组蛋白 产品包装(模拟)
  • RPC688Hu01.jpg Figure. SDS-PAGE
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPC688Hu01 骨诱导因子(OGN)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAC688Hu01 骨诱导因子(OGN)多克隆抗体 WB; IHC; ICC; IP.
LAC688Hu71 骨诱导因子(OGN)多克隆抗体(生物素标记) WB; IHC; ICC.
MAC688Hu22 骨诱导因子(OGN)单克隆抗体 WB; IHC; ICC; IP.
SEC688Hu 骨诱导因子(OGN)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC688Hu 骨诱导因子(OGN)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Bone. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. [pubmed:27836731]
Tohoku journal of experimental medicine Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. [pubmed:28824047]
Molecular Metabolism Osteoglycin, a novel coordinator of bone and glucose homeostasis [Pubmed:29799418]
Journal of Experimental & Clinical Cancer Research Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway [Pubmed:29499765]
Journal of Human Hypertension Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients [Pubmed:29867136]
Cell Reports Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue [Pubmed: 30332637]
J Clin Endocrinol Metab Osteoglycin across the adult lifespan [34850904]
留言咨询